The management of patients with Hodgkin's disease has changed a great deal over the last decade, with the introduction of staging laparotomies, improved radiotherapy techniques and effective combination chemotherapy. This book aims, in a series of chapters written by a variety of American authorities, to bring together the vast literature that has accumulated recently about this rare disease. It divides conveniently into three main sections: staging, treatment and complications of Hodgkin's disease.
The chapters on the accurate staging of the disease are informative and well illustrated.
The indications and surgical technique for staging laparotomy and splenectomy are covered in detail. Dr Lacher finishes the section by hoping that in the not so distant future the laparotomy/splenectomy procedure " will eventually be recalled only as a milestone in the history of Hodgkin's disease and management, important at the time, but abandoned because it was no longer needed ".
The section on treatment is not as clear and informative as the other parts of the book. Any haematologist who deals with leukaemic material knows that a significant minority of patients with clinically " acute " disease have blood and marrow pictures which are not readily classifiable by morphological criteria alone. This symposium, to which many distinguished clinical and experimental workers contributed, was an attempt to correlate " empirical " cytology and cytochemical methods with other characteristics of the leukaemic cell, such as immunological markers, cytogenetics, electron microscopy, cultural patterns and cell kinetics.
The book opens with an account of the undoubted limits of the present morphological classification of acute leukaemias by Flandrin and Bernard wNho nevertheless, surprisingly, found that only 2%0o of 1409 cases seen in their clinic were eventually labelled " undifferentiated leukaemia ". Galton and Dacie give a detailed analysis of material admitted to the 4th and 5th MRC trials on acute myeloblastic leukaemia. Some British haematologists have found it difficult to comprehend the subclassification of ALL given by Mathe, though most now recognise the microlymphoblastic and immunoblastic types; it is interesting that this classification includes prolymphocytic leukaemia as a variant of ALL and not CLL, as is sometimes assumed.
